Clinical nurse specialists can monitor for the signs of anaphylaxis, such as urticaria, hypotension, and shortness of breath. Pharmacists can monitor the patients for adverse drug reactions from drug therapy. Immunologists can monitor patients with severe asthma and add omalizumab (Anti-IgE) therapy when indicated according to GINA guidelines.